US 7163946
5-substituted 7,9-difluoro-5H-chromeno[3,4-f]quinoline compounds as selective progesterone receptor modulator compounds
granted A61PA61P15/00A61P15/08
Quick answer
US patent 7163946 (5-substituted 7,9-difluoro-5H-chromeno[3,4-f]quinoline compounds as selective progesterone receptor modulator compounds) held by Ligand Pharmaceuticals Incorporated expires Mon Jan 11 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ligand Pharmaceuticals Incorporated
- Grant date
- Tue Jan 16 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 11 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 25
- CPC classes
- A61P, A61P15/00, A61P15/08, A61P15/18, A61P19/10